Skip to main content

Advertisement

Log in

Development and evaluation of degradable hydroxyapatite/sodium silicate composite for low-dose drug delivery systems

  • Published:
Bulletin of Materials Science Aims and scope Submit manuscript

Abstract

This study was designed to develop innovative degradable hydroxyapatite (HAp)-based systems working as potential carriers for low-dose drugs. The HAp-based systems combine three components: HAp, sodium silicate and citric acid (HSC), which together could exhibit optimal characteristics as drug carriers. Both synthetic HAp (s-HAp) and extracted biological HAp (b-HAp) were used as sources of HAp due to their optimal biological properties and adsorption capacity. The s-HAp powder was prepared by co-precipitation method, while the b-HAp powder was extracted from bovine bone. Aqueous drug solutions of the atenolol, antihypertensive drug, were used as a model drug to investigate the drug release behaviour from HSC composites. The properties of s-HAP, b-HAp powders and HSC composite tablets were characterized by conventional methods. The results revealed that both s-HAp and b-HAp are pure powders and exhibited agglomerated microstructures with grain sizes less than 100 μm. The HSC composite tablets exhibited a dense structure, excellent compressive strength and excellent in-vitro release behaviour of atenolol. The results indicated that HAp powders and their composite tablets can be promised as economic raw materials and carriers for low-dose drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Habraken W J E M, Wolke J G C and Jansen J A 2007 Adv. Drug Deliver. Rev. 59 234

    Article  Google Scholar 

  2. Zheng J 2009 Formulation and analytical development for low-dose oral drug products (New Jersey: John Wiley & Sons Inc.)

    Book  Google Scholar 

  3. Lakshmanan S, Gupta G K, Avci P, Chandran R, Sadasivam M, Elisa A et al 2014, Adv. Drug Deliver. Rev. 71 98

    Article  Google Scholar 

  4. Zhou H and Lee J 2011 Acta Biomater. 7 2769

    Article  Google Scholar 

  5. Betsiou M, Bantsis G, Zoi I and Sikalidis C 2012 Ceram. Int. 38 2719

    Article  Google Scholar 

  6. Ginebra M P, Canal C, Espanol M, Pastorino D and Montufar E B 2012 Adv. Drug Deliver. Rev. 64 1090

    Article  Google Scholar 

  7. Öner M, Yetiz E, Ay V and Uysal U 2011 Ceram. Int. 37 2117

    Article  Google Scholar 

  8. Cosijns A, Vervaet C, Luyten J, Mullens S, Siepmann F, Van Hoorebeke L et al 2007, Eur. J. Pharm. Biopharm. 67 498

    Article  Google Scholar 

  9. Alexa I F, Ignat M, Popovici R F, Timpu D and Popovici E 2012 Int. J. Pharm. 436 111

    Article  Google Scholar 

  10. Sadat-Shojai M, Khorasani M T, Dinpanah-Khoshdargi E and Jamshidi A 2013 Acta Biomater. 9 7591

    Article  Google Scholar 

  11. Barakat N A M, Khalil K A, Sheikh F A, Omran A M, Gaihre B, Khil S M and Kim H Y 2008 Mater. Sci. Eng. C 28 1381

    Article  Google Scholar 

  12. Netz D J A, Sepulveda P, Pandolfelli V C, Spadaro A C C, Alencastre J B, Bentley M V L B and Marchetti J M 2001 Int. J. Pharm. 213 117

    Article  Google Scholar 

  13. Son J S, Appleford M, Ong J L, Wenke J C, Kim J M, Choi S H and Oh D S 2011 J. Control. Release 153 133

    Article  Google Scholar 

  14. Vernon B 2011 Injectable biomaterials: science and applications (Cambridge, UK: Woodhead Publishing Limited)

    Book  Google Scholar 

  15. Rahaman M N 2003 Ceramic processing and sintering (New York: Marcel Dekker Inc.) 2nd edn

  16. Miyaji F, Kim H -M, Handa S and Kokubo T 1999 Biomaterials 20 913

    Article  Google Scholar 

  17. Oliveira A L, Malafaya P B and Reis R L 2003 Biomaterials 24 2575

    Article  Google Scholar 

  18. Gottschalck T E and McEwen G N 2004 International cosmetic ingredient dictionary and handbook (Washington DC: CTFA) 10th ed., Vol. 1–4

  19. Jurkić L M, Cepanec I, Pavelić S K and Pavelić K 2013 Nutr. Metab. 10 2

    Article  Google Scholar 

  20. Liang W, Tu Y, Zhou H, Liu C and Rüssel C 2011 J. Non-Cryst. Solids 357 958

    Article  Google Scholar 

  21. Shoghi E, Fuguet E, Bosch E and Ràfols C 2013 Eur. J. Pharm. Sci. 48 291

    Article  Google Scholar 

  22. Siepe S, Lueckel B, Kramer A, Ries A and Gurny R 2006 Int. J. Pharm. 316 14

    Article  Google Scholar 

  23. Tatavarti A S and Hoag S W 2006 J. Pharm. Sci. 95 1459

    Article  Google Scholar 

  24. Nykänen P, Lempää S, Aaltonena M L, Jürjenson H, Veski P and Marvola M 2001 Int. J. Pharm. 229 155

    Article  Google Scholar 

  25. Peppas N A 1985 Pharm. Acta Helv. 60 110

    Google Scholar 

  26. Korsmeyer R W, Gurny R, Doelker E, Buri P and Peppas N A 1983 Int. J. Pharm. 15 25

    Article  Google Scholar 

  27. Morsy R, Elsayed M, Krause-Rehberg R, Dlubek G and Elnimr T 2010 J. Eur. Ceram. Soc. 30 1897

    Article  Google Scholar 

  28. Boutinguiza M, Pou J, Comesaña R, Lusquiños F, de Carlos A and León B 2012 Mater. Sci. Eng. C 32 478

    Article  Google Scholar 

  29. Venables H J and Wells J I 2001 Drug Dev. Ind. Pharm. 27 599

    Article  Google Scholar 

  30. Vromans H, Poels-Janssen H G M and Egermann H 1999 Pharm. Dev. Technol. 4 297

    Article  Google Scholar 

  31. Rathbone M I and Gurny R 2000 Controlled release veterinary drug delivery: biological and pharmaceutical considerations (Amsterdam: Elsevier Science)

  32. Saltzman W M 2001 Drug delivery: engineering principles for drug therapy (Oxford: Oxford University Press Inc.)

    Google Scholar 

  33. Maderuelo C, Zarzuelo A and Lanao J M 2011 J. Control. Release 154 2

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R MORSY.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

MORSY, R. Development and evaluation of degradable hydroxyapatite/sodium silicate composite for low-dose drug delivery systems. Bull Mater Sci 39, 1273–1278 (2016). https://doi.org/10.1007/s12034-016-1269-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12034-016-1269-9

Keywords

Navigation